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الكشف املتزامن عن املستضد الال بنيوي حلمى 
الدنك، باإلضافة إىل الغلوبولني املناعي G والغلوبولني 
املناعي M وتعداد الصفائح الدموية خالل تفشي 
الوباء
�ضوبا�س اأريا، نرمال اأجاروال، �ضاتب باريخ، �ضيخار اأجاروال
امللخ�ص: الهدف: خلل عام 2010 ، كانت هناك زيادة يف حالت العدوى بفريو�س حمى الدنك يف نيودلهي، الهند، مقارنة بعام 2009. 
اأجريت هذه الدرا�ضة يف م�ضت�ضفى �ضانت بارماناند خلل تف�ضي ذلك الوباء لتحديد فائدة "حزمة حمى الدنك" من اأجل الت�ضخي�س املبكر 
للحالت، واإجراء العلج الأف�ضل واتخاذ الإجراءات ال�رسيعة اللزمة من ناحية ال�ضحة العامة، وت�ضمل احلزمة الك�ضف املتزامن للربوتني الل 
بنيوي للدنك )1(، الغلوبولني املناعي امل�ضاد حلمى الدنك )M( و )G( وتعداد ال�ضفيحات الدموية، والعلج الأف�ضل للحالت وال�ضتجابة 
 )M( ال�رسيعة ال�ضحية العامة. الطريقة: مت اختبار عينات الدم للربوتني الل بنيوي للدنك )1(، والغلوبولني املناعي امل�ضاد حلمى الدنك 
و )G( با�ضتخدام تقنية الر�ضم املناعي امللون بخطوة واحدة، ومت تعداد ال�ضفائح الدموية باأجهزة التحليل التلقائي التي تعطي النتائج يف 
فرتة ل تزيد عن �ضاعتني. النتائج: من اأ�ضل 1886 مري�ضا مت فح�ضهم ب "حزمة حمى الدنك، ظهرت النتائج اإيجابية للربوتني الل بنيوي 
للدنك )1( يف 678 منهم فقط يف تركيبات خمتلفة. ويف 394 حالة كان الربوتني الل بنيوي حلمى الدنك )1( اإيجابيا ح�رسا، يف حني 
كانت 29 حالة اإيجابية اأي�ضا للغلوبولني املناعي امل�ضاد حلمى الدنك )G(. ويف 942 حالة كانت النتائج �ضلبية للربوتني الل بنيوي 
للدنك )1(، والغلوبولني املناعي امل�ضاد حلمى الدنك )M( و )G(. اأما تعداد ال�ضفيحات فكان اأقل عند املر�ضى الذين كان عندهم فح�س 
66.6–74.1 و  الثقة  الربوتني الل بنيوي حلمى الدنك )1( اإيجابيا )املتو�ضط والنحراف املعياري x 70.2±116.8 109/ليرت( فرتة 
الل  للربوتني  موجب  فح�س  ذي  20 مري�ضا  x 20< يف  ل  ال�ضفيحات109/  تعداد  كان   .)P>0.0001 )x 94.3±167.2 109/ل 
بنيوي حلمى الدنك )1( و 42 مري�ضا ذي فح�س �ضالب لذلك الربوتني. اخلال�صة: خلل وباء �ضنة 2010 �ضاعد التطبيق ال�رسيع "حلزمة 
حمى الدنك" يف علج املر�ضى، ونقل ال�ضفيحات، تنفيذ طرق مكافحة النواقل و اإخطارات ال�ضحة العامة. فح�س الربوتني الل بنيوي حلمى 
الدنك �ضاعد يف ت�ضخي�س 22.4% من احلالت الإ�ضافية، لدى 394 منهم عدوى اأولية بينما كان لدى 29 اآخرين عدوى ثانوية. كانت 
"حزمة حمى الدنك" مفيدة يف معاجلة احلالت امل�ضتبه فيها.
ِدلة ؛ امل�ضت�ضدات الفريو�ضية ؛ �ضفائح الدم ؛ عدد  َتعرْ َيِوّي؛ الأج�ضام امل�ضادة امُل�ضرْ ك ؛ الربوتني الفريو�ضي الَلِبنرْ نرْ ى الدَّ مفتاح الكلمات: فريو�س ُحمَّ
�ضفائح الدم.
abstract: Objectives: During 2010, there was an increase in dengue virus infections in New Delhi, India 
compared to 2009. This study was conducted at Sant Parmanand Hospital during this outbreak to determine the 
utility of a ‘Dengue Package’, comprising simultaneous detection of dengue non-structural protein 1 (NS1), anti-
dengue IgM, anti-dengue IgG and platelet enumeration for early diagnosis, better case management and faster 
public health response. Methods: Blood samples were tested for Dengue NS1, IgM and IgG using the single-
step immunochromatigrahic One-step dengue NS1 Ag and IgG/IgM test, while platelets were enumerated with 
automatic analysers yielding results within 1–2 hours. Results: Of the 1,886 patients screened with the ‘Dengue 
Package’, 678 and 1208 were NS1-positive and -negative respectively, in different combinations. In 394 cases, NS1 
was exclusively positive while 29 were also IgG positive. In 942 cases NS1, IgM and IgG were negative (triple 
negative). The platelet counts in the NS1 positives were lower than the NS1 negatives, mean and standard deviation 
(SD) 116.8±70.2 x 109/L: 95% confidence interval (CI) 66.6–74.1 and 167.2±94.0 x 109/L, P<0.0001. Platelet counts 
were <20 x 109/L in 20 NS1 antigen-positives and 42 NS1 antigen-negatives. Conclusion: During the 2010 outbreak, 
swift availability of the ‘Dengue Package’ assisted patient management, platelet transfusions, implementation of 
anti-vector measures and public health notifications. Testing for NS1 assisted the diagnosis of an additional 22.4% 
cases; of these 394 had evidence of primary infection and 29 of secondary infection. The ‘Dengue Package’ was 
useful in tackling the rise in suspected cases.
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During the late incubation period, or initial phase of dengue virus infection, laboratory disease confirmation is 
through viral isolation in cell culture and/or 
molecular investigations, or immunofluorescence, 
or immunohistochemistry.1 The dengue virus non-
structural antigen non-structural protein 1 (NS1) 
that develops right at the beginning of the feverish 
period and before the appearance of dengue IgM 
and/or IgG is emerging as a suitable option for 
dengue diagnosis.2 Consequent to a multi-country 
evaluation of two commercially available NS1 
enzyme-linked immunoabsorbent assay (ELISA) 
assays, a combination of NS1 and IgM detection 
in samples during the first few days of illness was 
recommended to increase overall dengue diagnostic 
sensitivity.3
Platelet therapy is a standard clinical practice for 
dengue patients with severe thrombocytopenia.4 
However, during introductory screening, a platelet 
count is not done in many cases. This results in 
delays in staring platelet therapy. During the 2010 
spurt in the incidence of dengue in New Delhi,5 
simultaneous screening for NS1, IgM and IgG and 
platelet enumeration was launched at the Sant 
Parmanand Hospital, a 140-bed tertiary care, multi-
disciplinary, private hospital in Delhi which caters 
to populations in the national capital and adjoining 
townships. The study was aimed to assess the utility 
of a concurrent identification of NS1, IgM, IgG, and 
platelet counting offered as the ‘Dengue Package’ 
for patients, clinicians and community.
Methods
During the period August to November 2010, 
samples from 1,886 suspected dengue patients 
were taken for testing by the combined ‘Dengue 
Package’ that included assays for NS1, IgM, IgG and 
automated platelet enumeration. Blood samples 
were collected by venipuncture in the hospital 
laboratory. They were drawn into ethylene diamine 
tetraacetic acid (EDTA) coated tubes and tested 
for dengue components employing the single-step 
immunochromatigrahic One-step dengue NS1 
Ag and IgG/IgM test, Dengue Duo, in accordance 
with the manufacturer’s instructions (Standard 
Diagnostics, Inc., St. Ingbert, Germany). The 
platelet enumeration was in the 5- or 3-differential 
analyzers, Coulter®AC. T5diff AL (Beckman 
Coulter, Fullerton, CA, USA) or BC-3000Plus 
(Mindary, Shenzhen, China). The individual reports 
were authenticated by two technologists and were 
available within 1–2 hours. Apart from the in-built 
controls in the One-step dengue NS1 Ag and IgG/
IgM test, Dengue Duo, no independent controls 
from NS1 antigen, IgM and IgG were used. Data 
were entered and analysed using the Statistical 
Package for Social Sciences (SPSS Inc, Chicago, IL, 
USA, Version 11.5). Non-parametric testing was 
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1. Concurrent assays for dengue virus non-structural protein 1 (NS1), anti-dengue IgM, anti-dengue IgG along with platelet enumeration 
in the ‘Dengue Package’ is immensely beneficial for patients, clinicians and public health officials.
2. Cases with a primary or secondary dengue virus infection in the initial febrile phase of illness will not escape detection with the ‘Dengue 
Package’.
3. Notifications to public health officials based on the results obtained by using the ‘Dengue Package’ would help in prompt initiation of 
anti-vector measures.
application to patient care
1. The ‘Dengue Package’ produces an earlier differential diagnosis in suspected cases enabling appropriate intervention and prevention of 
any death from shock.
2. Patients with severe thrombocytopenia, when diagnosed as positive by use of the ‘Dengue Package’, can be offered platelet infusions 
immediately.
3. Clinicians can discontinue the empirical use of antibiotics in patients who test positive for dengue virus infection by use of the ‘Dengue 
Package’.
4. It should be possible to implement anti-vector measures around hospitalised patients found positive by use of the ‘Dengue Package’. Such 
measures will protect against any cross-infection on hospital premises.
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carried out. P <0.05 was considered significant. 
The performance of this study was approved by the 
Director of our hospital.
Results
The patients tested by the ‘Dengue Package” were 
aged between  2 and 92 years, mean age 31.2 years: 
standard deviation (SI) 15.5 years, 95% confidence 
interval (CI) 2–62 years, 5th percentile 9 years and 
95th percentile 62 years. In 678 patients, the NS1 
antigen was detected with IgM and/or IgG while 
1,208 were likewise NS1-negative. Among the 678 
NS1-positive, 394 were exclusively positive for NS1, 
145 were also positive for IgM, and 29 for IgG and 
110 were positive for IgM and IgG (triple positive). 
The 1,208 NS1-negatives included 48 IgM-positives 
and 96 IgG-positives, while 122 were IgM-positive 
and IgG-positive and 942 were IgM and IgG 
negatives [Tables 1 and 2]. 
The platelet counts among the 678 NS1-positives 
were lower than the 1,208 NS1-negatives: the 
respective mean and SD were 116.8±70.2 x 109/L; 
95% CI 66.6–74.1 and 167.2±94.0 x 109/L 95% CI 
90.7–98.2 [Figure 1]; the Mann-Whitney, 2-tailed 
test gave P = 0.002. The average platelet counts 
were highest among 394 who were exclusively 
positive for NS1, 140.0±72.6 x 109/L. They were 
lowest among 29 who were co-positive for IgG, 
66.8±48.6 x 109/l; the Mann-Whitney, 2-tailed test P 
< 0.0001 [Figures 2 and 3]. There was no significant 
difference in platelet counts in cases who were 
positive for all  three markers, 69.2±40 x 109/L, or 
those positive  for NS1 and  IgG: and 66.8±48 x 
109/L. The counts in 145 IgM co-positives, 100±52 x 
109/L were higher than 110 triple-positives, 69.2±45 
x 109/L; the Mann-Whitney, 2-tailed test gave P < 
0.0001.
Among 1,208 NS1-negative cases, the average 
platelet counts were highest among 942 triple-
negatives, mean 84.7±90.25 x 109/L and lowest 
among 122 positives for IgM and IgG, mean 
86.1±77.7 x 109/L; the Mann-Whitney 2-tailed test 
gave P < 0.0001. The counts among 48 positive for 
IgM, 136.5±63.5 x 109/L were higher than for the 96 
co-positives for IgG and IgM, 114.3±84.7 x 109/L; 
the Mann-Whitney 2-tailed test P = 0.028 [Figure 
3].
Discussion
We initiated this feasibility study in August 2010 to 
ascertain the utility of concurrent testing of dengue 
virus NS1, IgM, IgG and platelet enumeration. 
The response was encouraging. Initial data on 175 
suspected cases of dengue showed that just a single 
laboratory visit was sufficient both for serology and 
platelet enumeration;6 consequently, the ‘Dengue 
Package’ was chosen by clinicians for patients with 
Table 1: Platelet counts as 109/L in 678 cases screened NS1 positive by ‘Dengue package’ testing at Sant Parmanand 
Hospital Delhi during the 2010 dengue outbreak














IgM negative IgG negative 394 139.9±72.6 3.66 10 481 4
IgM positive IgG negative 145 100.0±52.9 4.39 11 2.74 1
IgM negative IgG positive 29 66.8±48.6 9.04 10 210 3
IgM positive IgG positive 110 69.6±45.1 4.3 10 206 12
Table 2: Platelet counts as 109/L in 1208 cases screened NS1 negative by ‘Dengue package’ testing at Sant Parmanand 
Hospital during the 2010 dengue outbreak














IgM negative IgG positive 96 114.3±84.7 8.65 9 364 12
IgM positive IgG negative 48 136.5±63.5 9.71 13 302 3
IgM positive IgG positive 122 86.1±77.7 7.03 7 339 15
IgM negative IgG negative 942 184.7±90.2 29.4 5 693 12
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febrile illness.  
While working with the One step dengue NS1 Ag 
and IgG/IgM test, Dengue Duo, the in-built controls 
were used. For enumeration of platelets using 
different analysers, both internal quality control and 
external quality assessment were implemented. The 
performance of the BC-3000Plus (Mindary, Shenzhen, 
China) matched the results obtained on Coulter®Ac. 
TTm 5diff Autoloader (Beckman Coulter, Fullerton, 
CA, USA).7 The laboratory has participated in the 
Randox International Quality Assessment (RIQAS) 
programme for biochemistry for over three years;8 
consequently, laboratory technologists are well 
trained in constant quality control.
The platelet counts among the 678 NS1-
positives were lower than the 1,208 NS1-negatives: 
the respective mean and SD were 116.8±70.2 x 
109/L, 95%, CI 66.6–74.1 and 167.2±94.0 x 109/L, 
95% CI 90.7–98.2 [Figure 1]; Mann Whitney, 
2-tailed test gave P = 0.002. On average, the counts 
in exclusive NS1-positive cases were the highest, 
and lowest in those who were also IgG positives: 
139.8±3.6 X109/L and 66.8±9.04 x 109/L [Table 1], 
P < 0.0001. There was no significant difference in 
the counts in cases that were positive for all three 
markers and those positive for NS1 and IgG: 69.2±4 
x 109/L and 66.8±9 x 109/L. 
Among 1,208 NS1-negative cases, the average 
platelet counts were highest among those who 
were negative for IgG and IgM, mean 184.7±90.3 
x 109/L and lowest among 122 positives for IgM 
and IgG, mean 86.1±77.7 x 109/L. Mann-Whitney, 
2-tailed test gave P = 0.0001. The counts among 
48 positives for IgM 136.5±63.5 x 109/L were 
higher than the 96 co-positives for IgG and IgM, 
114.3±84.7 x 109/L; Mann-Whitney, 2-tailed, 
P = 0.0228 [Figure 3]. 
Among the 678 NS1-positive patients there 
were 394 who were negative for IgM [Table 1] and 
these would have otherwise been missed. They 
were suffering from a primary infection in the early 
phase of illness and were also viremic, i.e. they 
could transmit the virus if bitten by a mosquito. 
The 29 patients who were exclusively IgG positives, 
with a secondary viral infection, would have also 
been overlooked. Without NS1 screening they 
would have been labelled as “dengue negative”. They 
could have been infectious for mosquitoes during 
the earlier phase of illness. The concurrent NS1-
positive and IgM-positive status of 145 patients 
[Table 1] reinforced the utility of antigen detection 
during the earlier phase of illness. Furthermore, 110 
patients who were positive for NS1, IgM and IgG 
(triple-positives) [Table 1] were in the late stage of 
either a primary or a secondary infection and might 
have been infectious for mosquitoes. The NS1 
test in the ‘Dengue Package’ helped in diagnosing 
an additional 423 (394 NS1 and 35 IgG positives) 
otherwise IgM negative cases. Those would have 
been labelled negative if the dengue IgM alone had 
been used. The NS1 negatives included 48 IgM 
positives [Table 2] who had a primary infection 
presenting a later phase of illness. They were 
most likely IgG negative. It is unlikely that dengue 
IgG antibody levels became undetectable in the 
convalescent phase of illness. Furthermore, there 
were 96 cases that were positive only for IgG [Table 
2] who might have presented themselves for ‘Dengue 
Package’ fairly early during a secondary infection. A 
cell culture or reverse transcription polyermerase 




















Figure 2: Platelet counts as 109/L in NS1-positive as 
tested by the ‘Dengue Package’ at Sant Parmanand 
Hospital, Delhi.


















Figure 1: Platelet counts as 109/L in NS 1-positives and 
N 1-negatives tested by the ‘Dengue Package’ at Sant 
Parmanand Hospital, Delhi.
Legend: 1 = NS 1 positive; 2 = NS 1 negative
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exclude dengue virus replication. Furthermore, 122 
cases were positive for IgM and IgG [Table 2]. Such 
patients with a primary or secondary infection had 
presented in a later stage of illness. Dengue viruses 
are generally extruded from the host when IgM 
antibodies are present.  
Among the 1,208 cases who were NS1-negative 
there were 942 triple-negative cases. It would not 
be possible to rule out dengue infection in the 
negative cases without testing for viral replication 
in cell culture and/or molecular investigations or 
immunofluorescence, or immunohistochemistry;1 
facilities for these are not available in our hospital. 
Such patients should be investigated for acute 
febrile illnesses including malaria, urinary tract 
infection, enteric fever, Chikungunya virus and the 
influenza virus H1N1 infection.
Thrombocytopenia is observable in several 
patients with dengue virus infection. Cases with 
severe thrombocytopenia, platelet counts ≤30 x 
109/L (normal range = platelet counts of 150 to 400 
x 109/L), would need hospitalisation and/or platelet 
infusions.4 With the ‘Dengue Package’, it was 
possible to recognise 19 cases, four NS1 and IgM 
positive and three IgG positives [Table 1], and 12 
triple-negatives [Table 2]. They would have missed 
detection during any one-tier combined screening 
for NS1, IgG and IgM.
Platelet counts were generally higher in NS1-
positives than the NS1-negatives [Figure 1]. The 
average platelet counts in triple-negatives were 
highest. The counts were lowest among those with a 
secondary infection who were positive for NS1and 
IgG [Figure 2]. In both NS1 positive and negatives, 
they declined further upon production of IgM and 
IgG antibodies. There was a progressive decline 
in counts in cases presenting in later stages of 
illness. The platelet count in 12 NS1, IgM and IgG-
negatives was <20 x 109/L. It would not be possible 
to rule out dengue infection in such cases without 
testing for viral replication in cell culture and/or 
molecular investigations or immunofluorescence, 
or immunohistochemistry.1 This would help 
to differentiate between patients with dengue-
associated thrombocytopenia and those with severe 
bleeding episodes associated with trauma, invasive 
intensive care procedures or emergency surgery. 
Moreover, in patients with platelet count <20 x 
109/L, investigation for decreased megakaryocytic 
production, splenic sequestration, non-immune or 
immune destruction of platelets would need to be 
carried out.
The wide variation in the platelet counts of 
the patients [Tables 1 and 2] is natural since the 
mechanism of dengue related thrombocytopenia 
and coagulopathy is complex. It would involve 
platelet activation, pro-coagulant and anticoagulant 
arms of the coagulation system, complement, 
cytokines, and endothelial cells.7 Moreover, 
symptomatic thrombocytopenia would require 
platelet transfusion though platelet counts might 
not correlate well with clinical bleeding.
Public health officials were not notified about 
the 394 NS1-positive cases that were viremic 
and infectious to mosquitoes. Notifications are 
based on clinical and laboratory categorisation 
of a probable or confirmed case. As a rule rather 
than exception, WHO guidelines are applicable 
in dengue-endemic countries, including India.8 
Nevertheless, IgM and/or IgG positive patients 
were notified as probable cases. A mandate for 
NS1-based notification is awaited. That would be 
ideal for future comprehensive reporting of every 
probable case of dengue.
The ‘Dengue Package’ was beneficial during the 
outbreak since a single laboratory visit for serology 
and platelet enumeration was an asset for clinicians 
and patients. Based on results obtained with the 
‘Dengue Package’, platelet transfusion could be 
started straightaway. Those who were exclusively 
NS1-positives could be offered appropriate 
supportive therapy, thus avoiding any irrational 
usage of antibiotics. The patients and their 
attendants could be briefed regarding the basics of 
vector biology and provided with mosquito nets 





















Figure 3: Platelet counts as 109/L in NS1-negtives as 
tested by the ‘Dengue Package’ at Sant Parmanand 
Hospital, Delhi.
Legend: 1 = Triple negatives; 2 = IgG positives; 3 = IgG and IgM 
positive; 4 = IgM positive.
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NS1 testing in the ‘Dengue Package’, one could 
even distinguish between a secondary or past 
infection in a patient positive only for IgG antibody; 
the demonstrable NS1 will indicate a secondary 
infection.
There were limitations in the present study, 
conducted during an outbreak of dengue with a 
three-fold higher than normal workload. There 
was no gold standard obtainable for authentication. 
Apart from the in-built controls in the One-step 
Dengue NS1 Ag and IgG/IgM test, Dengue Duo, no 
independent third-party controls were employed 
during the outbreak. Facilities for molecular 
testing or cell culture were not available. Some of 
the NS1-negative, but IgG and IgM positive cases, 
might have evolved from a NS1-positive status to a 
NS1-negative stage when examined by the ‘Dengue 
Package’. Alternatively, there might have been other 
patients who had previously suffered from dengue 
virus infection. Unfortunately, none of them was 
available later to evaluate any seroconversion. 
Furthermore, precise details about the duration 
of fever and allied clinical presentations were not 
made available prior to the individual’s ‘Dengue 
Package’ testing in the hospital. 
The ‘Dengue Package’ has substantiated the 
earlier utility of enhanced diagnostic sensitivity of 
the combined antigen-antibody testing protocols. 
To our knowledge, there are no reports that 
contradict the simultaneous use of the dengue NS1 
antigen and antibody testing for disease diagnosis. 
A combined antibody and NS1 diagnostic 
protocol was reported during the 2007 dengue 
outbreak in Puerto Rico. Employing a 90% plaque-
reduction neutralisation test with dengue virus IgG 
depletion and NS1 antigen ELISA, it was possible to 
diagnose 85% of the 43 samples which could not be 
diagnosed using the standard diagnostic methods.12 
During the multi-country evaluation of two 
commercially available NS1 ELISA assays, a 
combination of NS1 and IgM detection in samples 
during the first few days was recommended to 
increase the overall dengue diagnostic sensitivity.3 
Evaluation of the Dengue Duo rapid test kit for 
detection of the NS1 antigen, IgM/ IgG antibody at 
the University of Malaysia on 320 dengue acute or 
convalescent sera in comparison with an in-house 
IgM capture ELISA, haemagglutination-inhibition 
test, or to real-time reverse transcription-
polymerase chain reaction (RT-PCR) was more 
affirmative. The rapid test kit was highly sensitive 
(88.65%) and highly specific (98.7%). NS1 and IgM 
detection by a rapid combined kit gave detection 
rates which were comparable to testing either by 
serology or RT-PCR.13
The circulation of dengue NS1, IgM and IgG 
antibodies was examined by using an in-house 
dengue type 1 (DENV1)-specific NS1 capture 
ELISA and the commercial Panbio Dengue IgM 
and IgG capture ELISA in Guangzhou in China. In 
a panel of 313 acute and early convalescent-phase 
sera from 140 DENV1 primary infected patients, 
NS1 detection was established in 81.8–91.1% 
samples during the first 7 days. The anti-dengue 
IgM antibody was detectable on the third day of 
onset with the positive rate of 42.9%, and rapidly 
increasing to 100% by the 8th day of illness. The 
anti-dengue IgG antibody was detectable on the 
fifth day of onset, with a low level in the first week 
of onset, and slowly increasing to 100% by the 15th 
day of illness. Combining the results of NS1 and 
IgM antibody detection allowed positive diagnosis 
in 96.9–100% of samples taken after day 3 of onset. 
A combination of dengue NS1 antigen and IgM 
antibody testing enhanced the rates of the disease 
diagnosis.14
The performance of the Standard Diagnostics 
(SD, South Korea) dengue virus SD dengue NS1 
Ag ELISA for dengue diagnosis on 320 dengue sera 
in Malaysia was compared with parallel real-time 
PCR, IgM capture ELISA and a haemagglutination-
inhibition assay. The NS1 antigen detection had a 
sensitivity and specificity of 76.76% and 98.31%, 
respectively. The assay was able to detect NS1 
antigen in the convalescent phase sera till the 14th 
day of illness. A combined assay with IgM and/or 
IgG was speculated to increase the NS1 sensitivity 
of detection still further.15 
Conclusion
Utilisation of the ‘Dengue Package’ can be important 
in the diagnosis of dengue virus infection in health 
care centres lacking sophisticated laboratory 
facilities as it means that one laboratory session 
would rule out dengue virus infection and also 
identify cases with severe thrombocytopenia 
who might have otherwise escaped detection. 
The ‘Dengue Package’ would enable physicians to 
offer rational therapy to their patients. They could 
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ask appropriate government agencies to initiate 
vector control measures including active disease 
surveillance. Last but not least, the one-stage 
‘Dengue Package’ should emerge as the ideal option 
for the management of patients with dengue since it 
would be economical during dengue outbreaks even 
at secondary or tertiary care health centres. Dengue 
outbreaks overpower outpatient and inpatient 
facilities in hospitals and both medical and health 
care personnel are rapidly exhausted.
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